SCHEMBL2365624

SCHEMBL2365624

Oc1cc2ccc3cccc4c5oc5c(c1O)c2c34

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
GAA P10253 3/20 0.40
HPGD P15428 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
THRB P10828 2/20 0.40
HSD17B10 Q99714 2/20 0.40
CDK2 P24941 2/20 0.40
MGAM O43451 2/20 0.40
SI P14410 2/20 0.40
MGAM2 Q2M2H8 2/20 0.40
KDM4E B2RXH2 1/20 0.40
INPPL1 O15357 1/20 0.40
NSD2 O96028 1/20 0.40
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
PABPC1 P11940 1/20 0.40
PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1129586 0.80 ALDH1A1 (0.59) ALDH1A1GAAHPGDMEN1KMT2A
SCHEMBL31017587 0.80 ALDH1A1 (0.49) ALDH1A1GAAHPGDMEN1KMT2A
SCHEMBL8381400 0.78 ALDH1A1 (0.59) ALDH1A1HPGDTHRBHSD17B10CYP3A4
SCHEMBL15476638 0.78 CYP1A2 (0.56) ALDH1A1HPGDTHRBHSD17B10CYP3A4
SCHEMBL9622094 0.75 ALDH1A1 (0.47) ALDH1A1GAAHPGDMEN1KMT2A
Pyrene SCHEMBL28151585 0.73 CYP1A2 (0.53) ALDH1A1GAAHPGDMEN1KMT2A
SCHEMBL29831525 0.73 CYP1A2 (0.53) ALDH1A1GAAHPGDMEN1KMT2A
SCHEMBL1229467 0.73 CYP1A2 (0.53) ALDH1A1GAAHPGDMEN1KMT2A
SCHEMBL28390349 0.73 TRPM4 (0.42) ALDH1A1GAAHPGDMEN1KMT2A
SCHEMBL2047161 0.73 CYP1A2 (0.57) ALDH1A1GAAHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2363133-A1 Composition comprising DNA fragments and medical and cosmetic uses thereof Trustees of Boston University (US) 2011-09-07 EP disclosed
US-7094766-B1 Use of locally applied DNA fragments TRUSTEES OF BOSTON UNIVERSITY (US) 2006-08-22 US disclosed
EP-1274410-A2 USE OF LOCALLY APPLIED DNA FRAGMENTS TRUSTEES OF BOSTON UNIVERSITY (US) 2003-01-15 EP disclosed
WO-2001074342-A2 USE OF LOCALLY APPLIED DNA FRAGMENTS TRUSTEES OF BOSTON UNIVERSITY (US) 2001-10-11 WO disclosed
US-6147056-A THERAPY FOR PSORIASIS TRUSTEES OF BOSTON UNIVERSITY (US) 2000-11-14 US disclosed
US-5525482-A EXPOSING HUMAN TEST CELLS, TRANSFORMED TO EXPRESSCYTOCHROME P450 ENZYMES, TO TOXIC MATERIALS; DETECTING GENE DAMAGE WAYNE STATE UNIVERSITY (US) 1996-06-11 US disclosed
EP-0297547-A2 Use of hydrolyzable tannins for treatement and prophylaxis of AIDS LEAD CHEMICAL COMPANY LTD. (JP) 1989-01-04 EP disclosed
EP-0062237-A1 Process for the determination of the carcinogenicity of chemical or physical agents YEDA RESEARCH AND DEVELOPMENT COMPANY, LTD. (IL) 1982-10-13 EP disclosed